Zobrazeno 1 - 10
of 68
pro vyhledávání: '"hepatocellar carcinoma"'
Autor:
Shalin Abraham, Adel Samson
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
In the last five years, the advent of combination immune checkpoint inhibitor atezolizumab and anti-angiogenic agent bevacizumab has transformed treatment of unresectable hepatocellular carcinoma. As patient outcomes improve, healthcare professionals
Externí odkaz:
https://doaj.org/article/6da110124b93492ba01db2215a448f93
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionPTGES3, also known as p23, is a molecule chaperone of Hsp90 that is involved in the pathogenesis of malignant tumors. Increasing studies have shown that PTGES3 plays a nonnegligible role in tumor development. However, analysis of PTGES3 i
Externí odkaz:
https://doaj.org/article/fe313c10b08e438c84deb5b7a320072a
Autor:
Feng Tian, Songyao Leng, Jian Chen, Yong Cao, Li Cao, Xiaojun Wang, Xuesong Li, Juan Wang, Shuguo Zheng, Jianwei Li
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundLaparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) has increased. However, the long-term outcomes of LLR for HCCs should be validated further. Besides, the validity of laparoscopic minor liver resection in difficult segme
Externí odkaz:
https://doaj.org/article/429686b4bcb44313bfaedbee6e7771c9
Autor:
Yu Pan, Geng-yuan Hu, Shi Jiang, Shun-jie Xia, Hendi Maher, Zhong-jie Lin, Qi-jiang Mao, Jie Zhao, Liu-xin Cai, Ying-hua Xu, Jun-jie Xu, Xiu-jun Cai
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Hepatocellular carcinoma (HCC) is a deadly tumor with high heterogeneity. Aerobic glycolysis is a common indicator of tumor growth and plays a key role in tumorigenesis. Heterogeneity in distinct metabolic pathways can be used to stratify HCC into cl
Externí odkaz:
https://doaj.org/article/80d3f44d42a1483099b4a09f68d6de89
Autor:
Roberto Minici, Michele Ammendola, Francesco Manti, Maria Anna Siciliano, Enrica Giglio, Marco Minici, Marica Melina, Giuseppe Currò, Domenico Laganà
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
In patients with early-stage hepatocellular carcinoma, awaiting liver transplantation, current guidelines by AASLD and ESMO recommend a bridging therapy with a loco-regional treatment to prevent progression outside transplantation criteria. The stand
Externí odkaz:
https://doaj.org/article/ba3d54e35bfc498a8cc02b54a41e27de
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Introduction: Associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) is a surgical procedure for liver malignancy where the volume of the liver remnant is estimated to be too small. We present the first case of two-stage
Externí odkaz:
https://doaj.org/article/61430a50e61146d291641b86223affbf
Autor:
Thomas B. Brunner, Dominik Bettinger, Michael Schultheiss, Lars Maruschke, Lukas Sturm, Nico Bartl, Ivana Koundurdjieva, Simon Kirste, Hannes P. Neeff, Christian Goetz, Nils Henrik Nicolay, Gabriele Ihorst, Fabian Bamberg, Robert Thimme, Anca-Ligia Grosu, Eleni Gkika
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The aim of this prospective observational trial was to evaluate the efficacy, toxicity and quality of life after stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) and to assess the results of this treatment in
Externí odkaz:
https://doaj.org/article/00287b64d0ed4adf955b5ad29e539f1f
Autor:
Muqi Li, Minni Liang, Tian Lan, Xiwen Wu, Wenxuan Xie, Tielong Wang, Zhitao Chen, Shunli Shen, Baogang Peng
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
BackgroundLong non-coding RNA (LncRNA) plays an important role in the occurrence and development of hepatocellular carcinoma (HCC). This study aims to establish an immune-related LncRNA model for risk assessment and prognosis prediction in HCC patien
Externí odkaz:
https://doaj.org/article/130853954e1e48968baa9fad67c6df0c
Autor:
Huancheng Wang, Jia Liu
Publikováno v:
Frontiers in Genetics, Vol 11 (2020)
PurposeThe aim of this study was to develop a comprehensive differential gene profile for hepatocellular carcinoma (HCC) patients treated with sorafenib.MethodsThe RNA sequencing data and miRNA sequencing data of 114 HCC patients treated with sorafen
Externí odkaz:
https://doaj.org/article/2b27e3b38b8449a291e5cf3b4190fa7f
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 4, Pp 81-92 (2017)
Derek J Erstad,1 Kenneth K Tanabe2–4 1Department of Surgery, Massachusetts General Hospital, 2Harvard Medical School, 3Division of Surgical Oncology, 4Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA Abs
Externí odkaz:
https://doaj.org/article/1bc507a0c1fd4ac49c08b6390d2815c0